Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.94 USD | -1.44% |
|
-6.85% | -30.25% |
15/05 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
14/05 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.25% | 310M | |
+26.52% | 52.73B | |
+37.49% | 39B | |
-9.23% | 38.52B | |
+29.46% | 30.38B | |
-12.26% | 26.39B | |
+10.72% | 26.08B | |
+45.15% | 14.15B | |
+32.36% | 12.6B | |
-5.99% | 11.51B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing